1h Free Analyst Time
The blood banking and blood products sector stands at a pivotal juncture where scientific innovation converges with evolving clinical demands to deliver life-saving therapies. Driven by breakthroughs in component processing, storage technologies, and safety protocols, this market ensures critical support for diverse patient populations-from trauma victims to those undergoing complex transplant surgeries. Over the next decade, stakeholders will navigate an increasingly intricate landscape shaped by regulatory transformations, emerging application areas, and geopolitical forces that influence supply chains and costs. As healthcare systems worldwide strive to enhance patient outcomes, they rely on a robust pipeline of high-quality blood components, ranging from red blood cells to plasma derivatives. This executive summary provides a concise yet comprehensive overview of key trends, policy shifts, and strategic imperatives relevant to manufacturers, blood service organizations, hospitals, and regulators. By synthesizing market intelligence on segmentation, regional dynamics, corporate benchmarking, and actionable recommendations, decision-makers can formulate resilient strategies to optimize operations, mitigate risk, and accelerate adoption of advanced capabilities. Subsequent sections delve into the transformative shifts reshaping the domain, analyze the implications of United States tariffs slated for 2025, and deliver targeted insights to guide investment and partnership decisions.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts Reshaping the Industry
The blood banking ecosystem is undergoing transformative shifts driven by technological innovation, evolving clinical needs, and heightened regulatory scrutiny. Next-generation pathogen reduction technologies now complement established nucleic acid amplification testing, enhancing safety and confidence in transfusion practices. Automation in blood processing equipment-including centrifugation systems and integrated sorters-streamlines component separation, while advanced cold-chain solutions such as Grade VII storage equipment ensure optimal preservation of plasma, platelets, and cellular products. On the clinical front, expanding indications for plasma derivatives in hemophilia treatment and novel cancer therapies underscore a growing demand for cryoprecipitate and fresh frozen plasma. Concurrently, autologous and directed donation models are gaining traction among elective surgical and regenerative medicine applications, challenging traditional reliance on voluntary non-remunerated donors. Digital platforms are further revolutionizing donor recruitment and traceability, enabling real-time inventory management across blood and tissue banks, hospitals, and diagnostics laboratories. As these dynamics unfold, industry participants must adapt their operational, regulatory, and strategic frameworks to harness new opportunities and safeguard supply resilience.Cumulative Impact of United States Tariffs in 2025
The United States’ plan to impose tariffs on imported blood processing equipment, reagents, and ancillary devices beginning in 2025 will exert multifaceted impacts on domestic and global stakeholders. Manufacturers of blood bags, anticoagulants, and sedimentation equipment-such as centrifuges and pipettes-will face increased input costs, compelling many to reevaluate sourcing strategies and seek cost-effective domestic suppliers. Diagnostics laboratories and hospitals reliant on specialized needles and pathogen reduction consumables could see margin pressures, prompting negotiations with vendors or shifts toward locally produced alternatives. On the revenue side, export-oriented players may leverage tariff-induced price adjustments to strengthen domestic market shares, though they risk contraction in international markets sensitive to price elasticity. Moreover, higher equipment prices could decelerate adoption of cutting-edge blood processing platforms among smaller clinics and community blood centers, potentially widening the gap between high-resource and resource-constrained facilities. In response, strategic alliances, joint ventures, or increased investment in regional manufacturing hubs are likely to emerge as key mitigation measures; proactive engagement with trade authorities and advocacy groups will also be critical to influence tariff structures and safeguard supply chain continuity.Key Segmentation Insights Across Market Dimensions
An in-depth segmentation analysis reveals nuanced opportunities and challenges across product, application, end-user, component, donor type, donation type, collection method, usage, safety measures, and storage and preservation categories. In the product type domain, plasma-further dissected into cryoprecipitate and fresh frozen plasma-commands robust therapeutic demand, while granulocytes, platelets, red blood cells, and whole blood maintain foundational roles in transfusion medicine. Application segmentation highlights the prominence of cancer treatment alongside aplastic anemia management, transplant surgeries, trauma care, and hemophilia therapies nested within broader blood disorder interventions. End-user environments range from high-throughput blood and tissue banks and hospitals to diagnostic laboratories, clinics, and research and development centers. Component insights draw attention to the critical contributions of blood bags, anticoagulants, needles, and blood processing equipment, with sedimentation tools such as centrifuges and pipettes gaining traction in advanced labs. Donor type breakdown underscores a balanced mix of paid, replacement, and voluntary non-remunerated donors, while donation models span allogenic, autologous, and directed protocols. Apheresis collection competes with manual blood collection methods, and usage patterns bifurcate between research applications and therapeutic applications. Finally, safety measures emphasize nucleic acid amplification testing and pathogen reduction technologies, complemented by Grade VII storage equipment and specialized transportation vials to uphold cold-chain integrity.Key Regional Insights Driving Growth and Access Trends
Regional dynamics in the blood banking sector reveal distinct growth trajectories shaped by healthcare infrastructure, regulatory frameworks, and donor demographics. In the Americas, established national transfusion services and robust R&D investments drive demand for advanced processing equipment and novel therapeutics, while public-private partnerships accelerate adoption of digital donor management systems. Europe, Middle East & Africa feature heterogeneous markets: Western Europe benefits from stringent safety regulations and high per-capita consumption of blood products, whereas emerging economies in the Middle East and Africa prioritize capacity-building initiatives and decentralized collection models to expand access. In the Asia-Pacific region, rapid economic growth, rising awareness of voluntary donation, and government-sponsored plasma fractionation programs are fueling market expansion; simultaneous investments in local manufacturing aim to reduce import dependencies and enhance affordability. Cross-regional collaborations, technology transfers, and harmonization of regulatory guidelines will be pivotal to address supply disparities and foster innovation across these geographies.Key Companies Insights and Competitive Landscape
Leading organizations are shaping the blood banking and blood products market through innovation, strategic partnerships, and global reach. ABBOTT LABORATORIES enhances diagnostic accuracy with integrated testing platforms, while the American Red Cross remains a cornerstone of voluntary donor mobilization and national blood reserves. Baxter International Inc. expands its portfolio with automated blood processing systems, and Cerus Corporation pioneers pathogen reduction solutions to bolster transfusion safety. CSL Behring leverages manufacturing scale for plasma-derived therapies, complemented by Fresenius Kabi’s focus on fractionation and bioprocessing technologies. Grifols S.A. drives global plasma sourcing and purification excellence, whereas Haemonetics Corporation delivers end-to-end collection and processing devices. Macopharma and Octapharma AG emphasize specialty biotherapeutics sourced from diverse donor pools, and Sanquin Scientific advances research into novel coagulation factors. Terumo Blood and Cell Technologies rounds out the competitive landscape with comprehensive apheresis collection platforms and innovative cold-chain solutions that address emerging clinical demands.Actionable Recommendations for Industry Leaders
Industry leaders must adopt agile strategies to navigate evolving market conditions and capitalize on emerging opportunities. First, investing in localized manufacturing and supply partnerships can mitigate the impact of tariffs and logistical disruptions, ensuring consistent access to critical consumables and equipment. Second, integrating advanced pathogen reduction and nucleic acid amplification testing into standard workflows will strengthen safety profiles and meet rising regulatory expectations. Third, leveraging digital donor engagement platforms and predictive analytics enhances recruitment efficiency and inventory forecasting, reducing wastage and supporting just-in-time distribution models. Fourth, diversifying product portfolios to encompass both therapeutic applications and research-focused offerings enables revenue resilience amid fluctuating demand; strategic alliances with biotech firms can accelerate innovation in plasma-derived and cell-based therapies. Finally, fostering collaborative relationships with regulatory bodies and participating in global harmonization initiatives positions organizations as thought leaders, facilitating smoother market entry and long-term growth.Conclusion and Strategic Imperatives
The blood banking and blood products market is poised for sustained innovation, yet success will hinge on the ability to adapt to regulatory shifts, geopolitical headwinds, and evolving clinical requirements. Robust safety protocols, agile supply chains, and targeted R&D investments will underpin competitive advantage. Organizations that embrace digital transformation-from automated processing to advanced analytics-will secure operational efficiencies and elevate patient care. Moreover, fostering cross-sector collaborations and public-private partnerships will accelerate technology adoption and expand access in underserved regions. By aligning strategic priorities with emerging therapeutic trends and regional nuances, stakeholders can navigate the next frontier of blood banking with confidence and purpose.Market Segmentation & Coverage
This research report categorizes the Blood Banking & Blood Products Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Granulocytes
- Plasma
- Cryoprecipitate
- Fresh Frozen Plasma
- Platelets
- Red Blood Cells
- Whole Blood
- Aplastic Anemia Treatment
- Blood Disorders
- Hemophilia Treatment
- Iron-Deficiency Anemia
- Cancer Treatment
- Transplant Surgeries
- Trauma and Surgery
- Blood and Tissue Banks
- Clinics
- Diagnostics Laboratories
- Hospitals
- Research and Development Centers
- Anticoagulants
- Blood Bags
- Blood Processing Equipment
- Needles
- Sedimentation Equipment
- Centrifuges
- Pipettes
- Paid Donors
- Replacement Donors
- Voluntary Non-Remunerated Donors
- Allogenic
- Autologous
- Directed Donation
- Apheresis Collection
- Manual Blood Collection
- Research Applications
- Therapeutic Applications
- Nucleic Acid Amplification Testing
- Pathogen Reduction Technologies
- Grade VII Storage Equipment
- Transportation Vials
This research report categorizes the Blood Banking & Blood Products Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Blood Banking & Blood Products Market to delves into recent significant developments and analyze trends in each of the following companies:
- ABBOTT LABORATORIES
- American Red Cross
- Baxter International Inc.
- Cerus Corporation
- CSL Behring
- Fresenius Kabi
- Grifols S.A.
- Haemonetics Corporation
- Macopharma
- Octapharma AG
- Sanquin Scientific
- Terumo Blood and Cell Technologies
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Banking & Blood Products Market, by Product Type
8.1. Introduction
8.2. Granulocytes
8.3. Plasma
8.3.1. Cryoprecipitate
8.3.2. Fresh Frozen Plasma
8.4. Platelets
8.5. Red Blood Cells
8.6. Whole Blood
9. Blood Banking & Blood Products Market, by Application
9.1. Introduction
9.2. Aplastic Anemia Treatment
9.3. Blood Disorders
9.3.1. Hemophilia Treatment
9.3.2. Iron-Deficiency Anemia
9.4. Cancer Treatment
9.5. Transplant Surgeries
9.6. Trauma and Surgery
10. Blood Banking & Blood Products Market, by End-User
10.1. Introduction
10.2. Blood and Tissue Banks
10.3. Clinics
10.4. Diagnostics Laboratories
10.5. Hospitals
10.6. Research and Development Centers
11. Blood Banking & Blood Products Market, by Component
11.1. Introduction
11.2. Anticoagulants
11.3. Blood Bags
11.4. Blood Processing Equipment
11.5. Needles
11.6. Sedimentation Equipment
11.6.1. Centrifuges
11.6.2. Pipettes
12. Blood Banking & Blood Products Market, by Donor Type
12.1. Introduction
12.2. Paid Donors
12.3. Replacement Donors
12.4. Voluntary Non-Remunerated Donors
13. Blood Banking & Blood Products Market, by Donation Type
13.1. Introduction
13.2. Allogenic
13.3. Autologous
13.4. Directed Donation
14. Blood Banking & Blood Products Market, by Collection Method
14.1. Introduction
14.2. Apheresis Collection
14.3. Manual Blood Collection
15. Blood Banking & Blood Products Market, by Usage
15.1. Introduction
15.2. Research Applications
15.3. Therapeutic Applications
16. Blood Banking & Blood Products Market, by Safety Measures
16.1. Introduction
16.2. Nucleic Acid Amplification Testing
16.3. Pathogen Reduction Technologies
17. Blood Banking & Blood Products Market, by Storage and Preservation
17.1. Introduction
17.2. Grade VII Storage Equipment
17.3. Transportation Vials
18. Americas Blood Banking & Blood Products Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Blood Banking & Blood Products Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Blood Banking & Blood Products Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. ABBOTT LABORATORIES
21.3.2. American Red Cross
21.3.3. Baxter International Inc.
21.3.4. Cerus Corporation
21.3.5. CSL Behring
21.3.6. Fresenius Kabi
21.3.7. Grifols S.A.
21.3.8. Haemonetics Corporation
21.3.9. Macopharma
21.3.10. Octapharma AG
21.3.11. Sanquin Scientific
21.3.12. Terumo Blood and Cell Technologies
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. BLOOD BANKING & BLOOD PRODUCTS MARKET MULTI-CURRENCY
FIGURE 2. BLOOD BANKING & BLOOD PRODUCTS MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD BANKING & BLOOD PRODUCTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. BLOOD BANKING & BLOOD PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. BLOOD BANKING & BLOOD PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD BANKING & BLOOD PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY GRANULOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APLASTIC ANEMIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IRON-DEFICIENCY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRANSPLANT SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRAUMA AND SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD AND TISSUE BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD PROCESSING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PIPETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PAID DONORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REPLACEMENT DONORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY VOLUNTARY NON-REMUNERATED DONORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIRECTED DONATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY GRADE VII STORAGE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRANSPORTATION VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 101. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 103. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 106. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 107. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 109. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 110. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 111. CANADA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 166. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 168. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 170. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 173. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 174. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 176. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 177. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 178. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 179. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 181. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 183. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 186. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 187. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 188. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 189. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 190. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 191. INDIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 205. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 207. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 209. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 211. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 212. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 213. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 214. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 215. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 216. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 217. JAPAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 285. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 289. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 290. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 292. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 293. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 294. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SAFETY MEASURES, 2018-2030 (USD MILLION)
TABLE 295. THAILAND BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY STORAGE AND PRESERVATION, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEDIMENTATION EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DONATION TYPE, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM BLOOD BANKING & BLOOD PRODUCTS MARKET S
Companies Mentioned
- ABBOTT LABORATORIES
- American Red Cross
- Baxter International Inc.
- Cerus Corporation
- CSL Behring
- Fresenius Kabi
- Grifols S.A.
- Haemonetics Corporation
- Macopharma
- Octapharma AG
- Sanquin Scientific
- Terumo Blood and Cell Technologies
Methodology
LOADING...
